Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica M Conway

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Plos Computational Biology|December 24, 2015
Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus PopulationTaina T Immonen, Jessica M Conway, Ethan O Romero-Severson, et al.
Plos Computational Biology|October 1, 2020
Models of SIV rebound after treatment interruption that involve multiple reactivation eventsChristiaan H van Dorp, Jessica M Conway, Dan H Barouch, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Machine Learning Reveals Distinct Immunogenic Signatures of Th1 Imprinting in ART-Treated Individuals with HIV Following Repeated SARS-CoV-2 VaccinationChapin S Korosec, Jessica M Conway, Vitaliy A Matveev, et al.
Patterns (New York, N.Y.)|April 24, 2026
Modeling of longitudinal immune profiles reveals distinct immunogenic signatures following five COVID-19 vaccinations among people living with HIVChapin S Korosec, Jessica M Conway, Vitaliy A Matveev, et al.
Vaccine|March 19, 2021
Importance of COVID-19 vaccine efficacy in older age groupsManish Sadarangani, Bahaa Abu Raya, Jessica M Conway, et al.
Frontiers in Microbiology|April 20, 2018
A New Age-Structured Multiscale Model of the Hepatitis C Virus Life-Cycle During Infection and Therapy With Direct-Acting Antiviral AgentsBarbara de M Quintela, Jessica M Conway, James M Hyman, et al.
Plos Pathogens|July 29, 2024
Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansionTin Phan, Jessica M Conway, Nicole Pagane, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansionTin Phan, Jessica M Conway, Nicole Pagane, et al.
Antiviral Therapy|June 11, 2014
Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapyLaetitia Canini, Swati DebRoy, Zoe Mariño, et al.
Science Advances|June 1, 2019
Defining early SIV replication and dissemination dynamics following vaginal transmissionClaire Deleage, Taina T Immonen, Christine M Fennessey, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Plos Computational Biology|December 24, 2015
Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus PopulationTaina T Immonen, Jessica M Conway, Ethan O Romero-Severson, et al.
Plos Computational Biology|October 1, 2020
Models of SIV rebound after treatment interruption that involve multiple reactivation eventsChristiaan H van Dorp, Jessica M Conway, Dan H Barouch, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Machine Learning Reveals Distinct Immunogenic Signatures of Th1 Imprinting in ART-Treated Individuals with HIV Following Repeated SARS-CoV-2 VaccinationChapin S Korosec, Jessica M Conway, Vitaliy A Matveev, et al.
Patterns (New York, N.Y.)|April 24, 2026
Modeling of longitudinal immune profiles reveals distinct immunogenic signatures following five COVID-19 vaccinations among people living with HIVChapin S Korosec, Jessica M Conway, Vitaliy A Matveev, et al.
Vaccine|March 19, 2021
Importance of COVID-19 vaccine efficacy in older age groupsManish Sadarangani, Bahaa Abu Raya, Jessica M Conway, et al.
Frontiers in Microbiology|April 20, 2018
A New Age-Structured Multiscale Model of the Hepatitis C Virus Life-Cycle During Infection and Therapy With Direct-Acting Antiviral AgentsBarbara de M Quintela, Jessica M Conway, James M Hyman, et al.
Plos Pathogens|July 29, 2024
Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansionTin Phan, Jessica M Conway, Nicole Pagane, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansionTin Phan, Jessica M Conway, Nicole Pagane, et al.
Antiviral Therapy|June 11, 2014
Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapyLaetitia Canini, Swati DebRoy, Zoe Mariño, et al.
Science Advances|June 1, 2019
Defining early SIV replication and dissemination dynamics following vaginal transmissionClaire Deleage, Taina T Immonen, Christine M Fennessey, et al.
Pageof 4